Acute reversible myocardial depression associated with sepsis

Internal Medicine

Volumn 42, Issue 1, 2003, Pages 60-65

  Kontani, Makoto ^a   Izumiya, Yoshiaki ^b   Shimizu, Miho ^b   Yasuma, Keiichi ^a   Inada, Akira ^b   Ohta, Hajime ^b   Ikeda, Takayuki ^a  

^a Tsuruga City Hospital   (Japan)

^b Tsuruga Municipal Hospital   (Japan)

Author keywords

Left ventricular failure; Proinflammatory cytokines; Sepsis

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CLINDAMYCIN; CYTOKINE; DOBUTAMINE; DOPAMINE; ERYTHROMYCIN; INTERLEUKIN 6; MEROPENEM; MESALAZINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; ARTERY CATHETER; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HYPOKINESIA; MALE; PNEUMONIA; PULMONARY ARTERY; SEPSIS; SEPTIC SHOCK;

EID: 0345270023     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.60     Document Type: Article

References (15)

1. Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54: 421-432, 1973.
2. Wilson RF, Thal AP, Kindling PH, Grifka T, Ackerman E. Hemodynamic measurements in septic shock. Arch Surg 91: 121-129, 1965.
3. Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483-490, 1984.
4. Parrillo JE. Pathogenetic mechanisms of septic shock. [see comments] N Engl J Med 328: 1471-1477, 1993.
5. Iwasaki M, Tamura T, Hikosaka M, et al. Acute left ventricular failure associated with sepsis. Shinzo 32: 721-726, 2000 (in Japanese).
6. Kumar A, Kumar A, Parrillo JE. Cytokines and septic myocardial depression: nitric oxide versus sphingosine/ceramide? [editorial; comment] Crit Care Med 27: 1391-1393, 1999.
7. Muller-Werdan U, Schumann H, Fuchs R, et al. Tumor necrosis factor-α (TNF-α) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide (NO)-synthase (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol 29: 2915-2923, 1997.
8. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. [see comments] N Engl J Med 321: 280-287, 1989.
9. Natanson C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169: 823-832, 1989.
10. Cain BS, Meldrum DR, Dinarello CA, et al. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function. [see comments] Crit Care Med 27: 1309-1318, 1999.
11. Sugishita K, Kinugawa K, Shimizu T, et al. Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling. J Mol Cell Cardiol 31: 1457-1467, 1999.
12. Dettbarn CA, Betto R, Salviati G, Palade P, Jenkins GM, Sabbadini RA. Modulation of cardiac sarcoplasmic reticulum ryanodine receptor by sphingosine. J Mol Cell Cardiol 26: 229-242, 1994.
13. Fukunaga H, Higuchi I, Usuki F, Moritoyo T, Okubo R. Clinical significance of serum cardiac myosin light chain I in patients with Duchenne muscular dystrophy. No To Shinkei 44: 131-135, 1992 (in Japanese, Abstract in English).
14. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215: 356-362, 1992.
15. Riche FC, Cholley BP, Panis YH, et al. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit Care Med 28: 433-437, 2000.